0001437749-23-032191.txt : 20231115 0001437749-23-032191.hdr.sgml : 20231115 20231115170355 ACCESSION NUMBER: 0001437749-23-032191 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231115 FILED AS OF DATE: 20231115 DATE AS OF CHANGE: 20231115 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Finn Jonathan CENTRAL INDEX KEY: 0001981595 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-35610 FILM NUMBER: 231411408 MAIL ADDRESS: STREET 1: C/O VANTAGE CONSULTING GROUP, INC. STREET 2: 3500 PACIFIC AVENUE CITY: VIRGINIA BEACH STATE: VA ZIP: 23451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATOSSA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001488039 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 264753208 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206.588.0256 MAIL ADDRESS: STREET 1: 107 SPRING STREET CITY: SEATTLE STATE: WA ZIP: 98104 FORMER COMPANY: FORMER CONFORMED NAME: ATOSSA GENETICS INC DATE OF NAME CHANGE: 20100325 4/A 1 rdgdoc.xml FORM 4/A X0508 4/A 2023-11-15 2023-11-15 0001488039 ATOSSA THERAPEUTICS, INC. ATOS 0001981595 Finn Jonathan C/O ATOSSA THERAPEUTICS, INC. 107 SPRING STREET SEATTLE WA 98104 1 0 Stock Option (right to buy) 0.65 2023-11-15 4 A 0 62500 0 A 2033-11-15 Common Stock 62500 62500 D The options shall vest in four equal quarterly installments following November 15, 2023. /s/ Heather Rees, as attorney-in-fact for Jonathan Finn 2023-11-15